Clinical Sites Network Alliance
BIOTrialMed has developed the Clinical Sites/PIs Network Alliance (CSNA), which contain 300+ top clinical research centers and experienced principal investigators globally. Aimed at optimizing the execution of clinical studies, these pre-qualified clinical centers and investigators leverage streamlined processes and offer quick study startup, increasing the success of a clinical study and lowering the study expenditures.
Rare Disease Center
Our Rare Disease Center offers clinical and commercialization solutions for orphan drugs. We help develop regulatory, clinical and commercial strategies and help secure resources for your trial.
Partnered with medical centers that focus on rare diseases in developing countries, we offer flexible and innovative solutions that recruit subjects and complete studies faster and reduce trial expenditures.
AI+ Clinical Trials
BIOTrialMed's AI-driven technologies streamline various aspects of clinical trials, from study design to data analysis and regulatory compliance. These technologies analyze vast amounts of data quickly and accurately, identifying patterns and insights that can optimize trial protocols and improve patient outcomes.
Key applications of AI+ clinical trial services:
-
Patient Recruitment and Retention
AI algorithms can analyze patient databases and electronic health records to identify eligible participants quickly. Predictive analytics help in targeting patient populations likely to adhere to trial protocols, thereby improving recruitment and retention rates.
-
Protocol Optimization
AI-driven simulations and predictive models assist in designing efficient trial protocols. By analyzing historical data and real-time inputs, AI helps optimize sample sizes, endpoints, and study duration, reducing costs and accelerating time-to-market.
-
Real-time Data Monitoring
AI-enabled tools continuously monitor incoming data for anomalies or trends, enabling early detection of issues and enhancing data quality. This proactive approach minimizes risks and ensures compliance with regulatory standards.
-
Personalized Medicine
AI algorithms analyze patient data to identify biomarkers and genetic profiles that can predict individual responses to treatments. This personalized approach supports the development of targeted therapies and improves overall trial success rates.
-
Risk Management and Compliance
AI platforms assist in navigating complex regulatory landscapes by ensuring adherence to protocols and guidelines. Automated reporting and audit trails enhance transparency and regulatory compliance throughout the trial process.
-
Predictive Analytics for Outcomes
AI models predict clinical outcomes based on various factors, facilitating informed decision-making and optimize trial success.
Comprehensive Processes Ensure Trials are Successful
BIOTrialMed’s multidisciplinary team of clinical pharmacologists, regulatory consultants, and clinical development experts interpret model results, employ quantitative and predictive tools, and provide clinical insights and shape regulatory strategy to help you make informed drug development decisions.
Rich Therapeutic Area Expertise
The BIOTrialMed team has abundant experience in a diverse number of therapeutic areas including oncology, vaccines, primary care, medical devices and others.
Latest Technological Trends and Platform
The BIOTrialMed team continues to build experiences in emerging technologies including gene therapy, immuno-oncology, and novel delivery platforms.
Efficient and flexible global team
BIOTrialMed offers highly customized solutions to meet our partners’ needs. We leverage our expertise and experience to efficiently design, prepare, execute, and deliver clinical results to meet the evolving demands in clinical research. Together with our academic and functional experts, we can provide you with guidance whether you are seeking esoteric or practical regulatory, medical, or clinical advice.
Full-process budget management and communication
BIOTrialMed closely collaborates with partners to ensure all our studies are delivered successfully on time, within budget, and are of the highest quality. Communication is prioritized, such that our partners receive detailed updates periodically. We provide comprehensive reports, metrics, and dashboards to ensure partners receive the right information at the right time to make informed decisions.
